DAWN R&D Expense Growth
Day One Biopharmaceuticals Inc · R&D Expense Growth
DAWN R&D Expense Growth
Latest reported-34.94%period ending
DAWN FY R&D Growth (YoY) (0.00% → -34.94%)
Latest values, visible window
High-resolution chart · PNG
DAWN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -34.9435% | |
| 74.4562% | |
| 52.4457% | |
| 96.4436% | |
| 378.9451% | |
| -34.5277% | |
| 0% |